Page last updated: 2024-09-05

etilevodopa and enkephalin, leucine-2-alanine

etilevodopa has been researched along with enkephalin, leucine-2-alanine in 1 studies

Compound Research Comparison

Studies
(etilevodopa)
Trials
(etilevodopa)
Recent Studies (post-2010)
(etilevodopa)
Studies
(enkephalin, leucine-2-alanine)
Trials
(enkephalin, leucine-2-alanine)
Recent Studies (post-2010) (enkephalin, leucine-2-alanine)
6221,5812374

Protein Interaction Comparison

ProteinTaxonomyetilevodopa (IC50)enkephalin, leucine-2-alanine (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.0915
Delta-type opioid receptorRattus norvegicus (Norway rat)0.0017
Kappa-type opioid receptorMus musculus (house mouse)0.009
Mu-type opioid receptorRattus norvegicus (Norway rat)0.0419
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)1.4691
Mu-type opioid receptorMus musculus (house mouse)0.009

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianucci, AM; Macchia, M; Massarelli, I; Minutolo, F; Prota, G1

Other Studies

1 other study(ies) available for etilevodopa and enkephalin, leucine-2-alanine

ArticleYear
QSAR models for predicting enzymatic hydrolysis of new chemical entities in 'soft-drug' design.
    Bioorganic & medicinal chemistry, 2009, May-15, Volume: 17, Issue:10

    Topics: Algorithms; Combinatorial Chemistry Techniques; Drug Design; Humans; Hydrolysis; Models, Chemical; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Stereoisomerism

2009